Outlook Therapeutics, Inc. - OTLK
Ownership (Schedule 13D / 13G) · latest 50 filings
· Back to all files
Visible: 0
| Filed | Form | Reporting person | Percent | Shares | SEC |
|---|---|---|---|---|---|
| Apr 24, 2026 | SCHEDULE 13G | Mitchell P. Kopin | 4.99% | 5,990,447 | View |
| Apr 24, 2026 | SCHEDULE 13G | Daniel B. Asher | 4.99% | 5,990,447 | View |
| Apr 24, 2026 | SCHEDULE 13G | Intracoastal Capital LLC | 4.99% | 5,990,447 | View |
| Feb 05, 2026 | SCHEDULE 13G/A | Sphera Funds Management Ltd. | 4.69% | 3,153,856 | View |
| Feb 05, 2026 | SCHEDULE 13G/A | Sphera Global Healthcare GP Ltd. | 4.69% | 3,153,856 | View |
| Feb 05, 2026 | SCHEDULE 13G/A | Sphera Global Healthcare Management LP. | 4.69% | 3,153,856 | View |
Percent = "% of class represented by amount beneficially owned" for this reporting person in the filed 13D/13G.
Shares = reported beneficial ownership amount for the same row (not portfolio shares from 13F).
Amendments (/A) can repeat the same holder over time, so rows should not be summed.
Extraction is best-effort from filing text and can be missing or noisy; verify exact figures via the SEC link in each row.